World's Best Scientists 2026 revealed!
Diabetes and Metabolism
H-index 31

Diabetes and Metabolism

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 656 136 158 30

Additional Metrics

Number of Best Scientists*: 166
Documents by Best Scientists*: 169
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 110
SCIMAGO SJR: 1.648
Impact Factor: 4.7

Overview

Top Research Topics at Diabetes & Metabolism?

The objective of the journal is to combine knowledge in the areas of Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Insulin. The concepts on Internal medicine presented in it can also apply to other research fields, including Gastroenterology, Type 2 Diabetes Mellitus and Cardiology. Obesity, Surgery, Pediatrics and Risk factor are some topics wherein Diabetes mellitus research discussed in Diabetes & Metabolism have an impact.

  • Internal medicine (22.77%)
  • Diabetes mellitus (18.21%)
  • Endocrinology (16.07%)

What are the most cited papers published in the journal?

  • Adipokines: The missing link between insulin resistance and obesity (573 citations)
  • Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome (481 citations)
  • Consequences of the diabetic status on the oxidant/antioxidant balance. (372 citations)

Research areas of the most cited articles at Diabetes & Metabolism:

The most cited publications mostly deal with topics like Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Insulin resistance. The journal publications focus on Internal medicine research which is adjacent to topics in Cardiology. Aside from discussions in Diabetes mellitus, the published articles also deal with the subject of Surgery which intersects with Diabetic foot disciplines.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Diabetes mellitus
  • Disease

The previous edition focused in particular on these issues:

The foci of the journal are Internal medicine, Diabetes mellitus, Type 2 diabetes, Type 1 diabetes and In patient. The journal addresses concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology, Endocrinology, Type 2 Diabetes Mellitus and Cardiology. The subject of Insulin, which is connected to the field of Pregnancy, serves as the foundation of the Type 2 Diabetes Mellitus research featured in the journal.

While Diabetes mellitus is the focus of the journal, it also provided insights into the studies of Observational study, Incidence (epidemiology), Disease, Myocardial infarction and Risk factor. The studies on Type 2 diabetes discussed can also contribute to research in the domains of Urology, Blood pressure, Placebo, Hazard ratio and Mean age. The work on Type 1 diabetes tackled in it brings together disciplines like Diabetic ketoacidosis, Anesthesia and Intensive care medicine.

The most cited articles from the last journal are:

  • Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis. (65 citations)
  • Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study. (33 citations)
  • Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. (25 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Diabetes & Metabolism (based on the number of publications) are:

  • Paul Valensi (235 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Emmanuel Cosson (178 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • André Scheen (105 papers) published 5 papers at the last edition the same number as at the previous edition,
  • B. Balkau (105 papers) absent at the last edition,
  • Bruno Guerci (104 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Diabetes & Metabolism (based on the number of publications) are:

  • French Institute of Health and Medical Research (962 papers) published 4 papers at the last edition, 8 less than at the previous edition,
  • University of Paris (204 papers) published 18 papers at the last edition, 7 more than at the previous edition,
  • Centre national de la recherche scientifique (149 papers) published 1 paper at the last edition,
  • Paris Diderot University (100 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Pierre-and-Marie-Curie University (99 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.62% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.15% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 9.28% of all publications and 58.76% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities for Researchers in Diabetes and Metabolism

One important segment that seems to be missing from this comprehensive review of the Diabetes & Metabolism journal is an insightful section on the potential career opportunities and pathways for budding researchers in these fields. This information would offer a practical dimension to the theoretical and academic aspects discussed throughout the article. Researchers who gain exposure and proficiency in topics like internal medicine, diabetes mellitus, endocrinology, and other related fields can find fulfilling and impactful career paths. Potential directions include essential roles in healthcare institutions, research organizations, pharmaceutical companies, and educational settings. As well, these professionals could consider transitioning into digital healthcare platforms, leveraging their expertise in emerging fields like telehealth or online nursing. For instance, experienced practitioners with sufficient academic credentials can consider working as course instructors for online nursing programs in Hawaii, given the growth of online education. Such a transition allows researchers to directly influence the next generation of healthcare professionals, sharing their unique insights and academic findings in a practical, application-based manner. Naturally, career opportunities will depend on a host of factors including individual qualifications, career aspirations, locations, and the current market needs. With the right blend of professional experience and academic excellence, researchers in the fields of Diabetes and Metabolism have various avenues to contribute positively to healthcare societies worldwide.

Top Publications

  • Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

    M.S. Capehorn;A.-M. Catarig;J.K. Furberg;A. Janez

    (2020)
    286 Citations
  • Metformin and COVID-19: From cellular mechanisms to reduced mortality.

    André J Scheen

    (2020)
    176 Citations
  • Patients with diabetes are at higher risk for severe illness from COVID-19.

    Giovanni Targher;Alessandro Mantovani;Xiao-Bo Wang;Hua-Dong Yan

    (2020)
    165 Citations
  • Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.

    André J Scheen;Michel Marre;Charles Thivolet

    (2020)
    163 Citations
  • Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.

    Raffaele Marfella;Pasquale Paolisso;Celestino Sardu;Celestino Sardu;Luca Bergamaschi

    (2020)
    122 Citations
  • Socioeconomic inequalities and type 2 diabetes complications: A systematic review.

    S. Tatulashvili;G. Fagherazzi;C. Dow;R. Cohen

    (2020)
    118 Citations
  • NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment.

    Giovanni Targher;Kathleen E. Corey;Christopher D. Byrne

    (2021)
    116 Citations
  • Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.

    A. Mantovani;C.D. Byrne;E. Scorletti;C.S. Mantzoros

    (2020)
    115 Citations
  • Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes.

    Thirunavukkarasu Sathish;Robyn J Tapp;Mark E Cooper;Paul Zimmet

    (2021)
    99 Citations
  • Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.

    Bertrand Cariou;Thomas Goronflot;Antoine Rimbert;Sandrine Boullu

    (2021)
    96 Citations

Related Online Degrees & Career Pathways

For those interested in medicine but seeking diverse entry points, several related online degrees offer flexible pathways into the healthcare field. One popular option is pursuing medical billing and coding, which provides specialized skills essential for managing patient data and insurance claims, often with affordable online programs.

Nursing is another vital healthcare profession, and many students consider programs with high acceptance rates to facilitate easier entry. Exploring nursing schools with high acceptance rates can be a strategic choice for aspiring nurses seeking accessible yet quality education.

For those drawn to leadership roles within healthcare, online options in administration are increasingly popular. The best accelerated healthcare administration degree programs online offer fast-track options to build skills in managing healthcare systems and improving patient care efficiency.

Moreover, students looking for cost-effective study options can review lists of health administration degrees online that combine affordability with comprehensive curricula, preparing graduates for diverse administrative roles across the healthcare industry.

Best Scientists Contributing to This Journal

Recently Published Articles